scispace - formally typeset
Z

Zachary Freyberg

Researcher at University of Pittsburgh

Publications -  81
Citations -  2594

Zachary Freyberg is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Medicine & Dopamine. The author has an hindex of 21, co-authored 59 publications receiving 1994 citations. Previous affiliations of Zachary Freyberg include Columbia University & Cornell University.

Papers
More filters
Journal ArticleDOI

Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action

TL;DR: Evidence that Akt/GSK-3 and Wnt-related pathways are involved in the pathogenesis of schizophrenia as well as details of intracellular events related to these molecules mediated by both typical and atypical antipsychotic medications are reviewed.
Journal ArticleDOI

Amphiphysin II (SH3P9; BIN1), a Member of the Amphiphysin/Rvs Family, Is Concentrated in the Cortical Cytomatrix of Axon Initial Segments and Nodes of Ranvier in Brain and around T Tubules in Skeletal Muscle

TL;DR: The hypothesis that, even in mammalian cells, amphiphysin/Rvs family members have a role both in endocytosis and in actin function is supported and it is suggested that distinct amphiphYSin isoforms contribute to define distinct domains of the cortical cytoplasm.
Journal ArticleDOI

Intracellular Localization of Phospholipase D1 in Mammalian Cells

TL;DR: The data show that the intracellular localization of PLD1 is consistent with a role in vesicle trafficking from the Golgi apparatus and suggest that it also functions in the cell nucleus.
Journal ArticleDOI

Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease

TL;DR: It is shown that C99, in addition to its localization in endosomes, can also be found in MAM, where it is normally processed rapidly by γ‐secretase, and this change in mitochondrial membrane composition interferes with the proper assembly and activity of mitochondrial respiratory supercomplexes, thereby likely contributing to the bioenergetic defects characteristic of AD.
Journal ArticleDOI

Signaling pathways in schizophrenia: emerging targets and therapeutic strategies.

TL;DR: This work reviews targeted approaches for pharmacotherapy involving the glutamatergic, GABAergic and cholinergic pathways, and describes several of the major genetic findings that identify signaling pathways representing potential targets for novel pharmacological intervention.